InterCure Ltd (INCR) Down 7.14% in Premarket Trading

InterCure Ltd (INCR) is lower by Monday morning, with the stock declining -7.14% in pre-market trading to 1.43. INCR's short-term technical score of 6 indicates that the stock has traded less bullishly over the last month than 94% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 125 out of 146 industries, the stock ranks higher than 14% of stocks. InterCure Ltd has fallen 8.33% over the past month, closing at $1.70 on September 11. During this period of time, the stock fell as low as $1.50 and as high as $1.76. INCR has an average analyst recommendation of Strong Buy. The company has an average price target of $5.00.

INCR has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on INCR!

See Full INCR Report

InterCure Ltd has a Long-Term Technical rank of 19. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 81% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 71 by this metric, INCR ranks better than 71% of stocks.

Important Dates for Investors in INCR:

-InterCure Ltd is set to release earnings on 2023-11-21. Over the last 12 months, the company has reported EPS of $0.81. -We do not have a set dividend date for InterCure Ltd at this time. Click Here To Get The Full Report on InterCure Ltd (INCR)